{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:06:59Z","timestamp":1788937619809,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274346"],"award-info":[{"award-number":["82274346"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242256"],"award-info":[{"award-number":["7242256"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xiyuan Hospital CACMS Enhancement Fund","award":["XYZX0101-36"],"award-info":[{"award-number":["XYZX0101-36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08835-2","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:54:41Z","timestamp":1788882881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tet2 deficiency drives age-related heterogeneous progression of myeloid neoplasms through epigenetic-immune microenvironment imbalance"],"prefix":"10.1186","volume":"24","author":[{"given":"Yanxi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiupeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"8835_CR1","doi-asserted-by":"crossref","unstructured":"Loghavi S, Kanagal-Shamanna R, Khoury JD, Medeiros LJ, Naresh KN, Nejati R, Patnaik MM. WHO 5th Edition Classification Project. Fifth edition of the World Health Classification of tumors of the hematopoietic and lymphoid tissue: myeloid neoplasms. Mod Pathol. 2024 Feb;37(2):100397.","DOI":"10.1016\/j.modpat.2023.100397"},{"key":"8835_CR2","doi-asserted-by":"crossref","unstructured":"Huang HT, Figueroa ME. Epigenetic deregulation in myeloid malignancies. Blood. 2021 Aug 26; 138(8):613\u2013624.","DOI":"10.1182\/blood.2019004262"},{"key":"8835_CR3","doi-asserted-by":"crossref","unstructured":"Delatte B, Deplus R, Fuks F. Playing TET ris with DNA modifications. EMBO J. 2014;33:1198\u20131211.","DOI":"10.15252\/embj.201488290"},{"key":"8835_CR4","doi-asserted-by":"crossref","unstructured":"Cimmino L, Dolgalev I, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017 Sep 7;170(6):1079-1095.e20.","DOI":"10.1016\/j.cell.2017.07.032"},{"key":"8835_CR5","doi-asserted-by":"crossref","unstructured":"Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia. 2014;28:485\u2013496.","DOI":"10.1038\/leu.2013.337"},{"key":"8835_CR6","doi-asserted-by":"crossref","unstructured":"Li Z, Cai X, Cai CL, Wang J, Zhang W, Petersen BE, Xu M. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. 2011;118,4509\u201318.","DOI":"10.1182\/blood-2010-12-325241"},{"key":"8835_CR7","doi-asserted-by":"crossref","unstructured":"Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289\u2013301.","DOI":"10.1056\/NEJMoa0810069"},{"key":"8835_CR8","doi-asserted-by":"crossref","unstructured":"Langemeijer SM, Kuiper RP, Berends M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838\u201342.","DOI":"10.1038\/ng.391"},{"key":"8835_CR9","doi-asserted-by":"crossref","unstructured":"Tefferi A, Pardanani A, Lim KH, et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia. 2009;23(5):905\u201311.","DOI":"10.1038\/leu.2009.47"},{"issue":"9","key":"8835_CR10","first-page":"1861","volume":"27","author":"VannucchiAM,LashoTL","year":"2013","unstructured":"Vannucchi AM, Lasho TL, Guglielmelli P, et al Mutations and prognosis in primary myelofibrosis Leuk. 2013;27(9):1861\u20139.","journal-title":"GuglielmelliP etal Mutationsandprognosisinprimarymyelofibrosis Leuk"},{"key":"8835_CR11","doi-asserted-by":"crossref","unstructured":"Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014 Dec 25;371(26):2488\u201398.","DOI":"10.1056\/NEJMoa1408617"},{"key":"8835_CR12","doi-asserted-by":"crossref","unstructured":"Henning AN, Roychoudhuri R, Restifo NP. Epigenetic control of CD8+ T cell differentiation. Nat Rev Immunol. 2018 May;18(5):340\u201356.","DOI":"10.1038\/nri.2017.146"},{"key":"8835_CR13","doi-asserted-by":"crossref","unstructured":"Scharer CD, Barwick BG, Youngblood BA, Ahmed R, Boss JM. Global DNA methylation remodeling accompanies CD8 T cell effector function. J Immunol. 2013 Sep 15;191(6):3419\u201329.","DOI":"10.4049\/jimmunol.1301395"},{"key":"8835_CR14","doi-asserted-by":"crossref","unstructured":"Rodriguez RM, Suarez-Alvarez B, Lav\u00edn JL, Mos\u00e9n-Ansorena D, Baraga\u00f1o Raneros A, M\u00e1rquez-Kisinousky L, Aransay AM, Lopez-Larrea C. Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8+ T cells. J Immunol. 2017;198(2):937\u2013949.","DOI":"10.4049\/jimmunol.1601102"},{"key":"8835_CR15","doi-asserted-by":"crossref","unstructured":"Kanno Y, Vahedi G, Hirahara K, Singleton K, O'Shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol. 2012;30:707\u2009\u2013\u200931.","DOI":"10.1146\/annurev-immunol-020711-075058"},{"key":"8835_CR16","doi-asserted-by":"crossref","unstructured":"Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol. 2009;9:91\u2013105.","DOI":"10.1038\/nri2487"},{"key":"8835_CR17","doi-asserted-by":"crossref","unstructured":"Kitagawa Y, Ohkura N, Sakaguchi S. Epigenetic control of thymic Treg-cell development. Eur J Immunol. 2015 Jan;45(1):11\u2009\u2013\u20096.","DOI":"10.1002\/eji.201444577"},{"key":"8835_CR18","doi-asserted-by":"crossref","unstructured":"Cong B, Zhang Q, Cao X. The function and regulation of TET2 in innate immunity and inflammation. Protein Cell. 2021 Mar;12(3):165\u201373.","DOI":"10.1007\/s13238-020-00796-6"},{"key":"8835_CR19","doi-asserted-by":"crossref","unstructured":"Jiang S. Tet2 at the interface between cancer and immunity. Commun Biol. 2020 Nov 12;3(1):667.","DOI":"10.1038\/s42003-020-01391-5"},{"key":"8835_CR20","doi-asserted-by":"crossref","unstructured":"Menter T, Tzankov A. Tumor microenvironment in acute myeloid leukemia: adjusting niches. Front Immunol. 2022 Feb 22;13:811144.","DOI":"10.3389\/fimmu.2022.811144"},{"key":"8835_CR21","doi-asserted-by":"crossref","unstructured":"Vadakekolathu J, Rutella S. Escape from T-cell-targeting immunotherapies in acute myeloid leukemia. Blood. 2024;143(26):2689\u2013700.","DOI":"10.1182\/blood.2023019961"},{"key":"8835_CR22","doi-asserted-by":"crossref","unstructured":"Wang J, Miao Z, Jiang Y, Zou P, Li W, Tang X, Lv Y, Xing D, Chen S, Yang F, Xu M, Cao Z, Wang H, Zhao Z. Characteristics of myeloid sarcoma in mice and patients with Tet2 deficiency. Oncol Lett. 2020 Jun;19(6):3789\u201398.","DOI":"10.3892\/ol.2020.11479"},{"issue":"10","key":"8835_CR23","doi-asserted-by":"publisher","first-page":"e184021","DOI":"10.1172\/JCI184021","volume":"135","author":"P Zhang","year":"2025","unstructured":"Zhang P, Whipp EC, Skuli SJ, Gharghabi M, Saygin C, Sher SA, Carroll M, Pan X, Eisenmann ED, Lai TH, Harrington BK, Chan WK, Youssef Y, Chen B, Penson A, Lewis AM, Castro CR, Fox N, Cihan A, Le Luduec JB, DeWolf S, Kauffman T, Mims AS, Canfield D, Phillips H, Williams KE, Shaffer J, Lozanski A, Doong TJ, Lozanski G, Mao C, Walker CJ, Blachly JS, Daniyan AF, Alinari L, Baiocchi RA, Yang Y, Grieselhuber NR, Campbell MJ, Baker SD, Blaser BW, Abdel-Wahab O, Lapalombella R. TP53 mutations and Tet2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment. J Clin Invest. 2025;135(10):e184021.","journal-title":"J Clin Invest"},{"key":"8835_CR24","doi-asserted-by":"crossref","unstructured":"Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011 Jul 12;20(1):11\u201324.","DOI":"10.1016\/j.ccr.2011.06.001"},{"key":"8835_CR25","doi-asserted-by":"crossref","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014 Dec 25;371(26):2477-87.","DOI":"10.1056\/NEJMoa1409405"},{"key":"8835_CR26","doi-asserted-by":"publisher","unstructured":"Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114:144\u20137. https:\/\/doi.org\/10.1182\/blood-2009-03-210039.","DOI":"10.1182\/blood-2009-03-210039"},{"key":"8835_CR27","doi-asserted-by":"crossref","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18:553\u201367.","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"8835_CR28","doi-asserted-by":"crossref","unstructured":"Ito K, Lee J, Chrysanthou S, Zhao Y, Josephs K, Sato H, et al. Non-catalytic roles of Tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis. Cell Rep. 2019;28(10):2480\u2013e24904.","DOI":"10.1016\/j.celrep.2019.07.094"},{"key":"8835_CR29","doi-asserted-by":"crossref","unstructured":"Jiang S. Tet2 at the interface between cancer and immunity. Commun Biol. 2020;3(1):667.","DOI":"10.1038\/s42003-020-01391-5"},{"issue":"3","key":"8835_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13238-020-00796-6","volume":"12","author":"B Cong","year":"2021","unstructured":"Cong B, Zhang Q, Cao X. The function and regulation of Tet2 in innate immunity and inflammation. Protein Cell. 2021;12(3):165\u201373.","journal-title":"Protein Cell"},{"issue":"5","key":"8835_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri.2017.146","volume":"18","author":"AN Henning","year":"2018","unstructured":"Henning AN, Roychoudhuri R, Restifo NP. Epigenetic control of CD8\u2009+\u2009T cell differentiation. Nat Rev Immunol. 2018;18(5):340\u201356.","journal-title":"Nat Rev Immunol"},{"key":"8835_CR32","doi-asserted-by":"publisher","first-page":"104747","DOI":"10.1016\/j.exphem.2025.104747","volume":"145","author":"SM Holmes","year":"2025","unstructured":"Holmes SM, Wells CJ, Hall C, McNaughton AJM, Rauh MJ, Abraham SA. Sex differences alter primitive progenitors in the C57BL\/6 Tet2 knockout mouse model. Exp Hematol. 2025;145:104747.","journal-title":"Exp Hematol"},{"issue":"10","key":"8835_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90. Epub 2016 Aug 22.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8835_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41581-023-00787-w","volume":"20","author":"SE Dunn","year":"2024","unstructured":"Dunn SE, Perry WA, Klein SL. Mechanisms and consequences of sex differences in immune responses. Nat Rev Nephrol. 2024;20(1):37\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"7913","key":"8835_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens THH, Spencer DH, Machado H, Lee-Six H, Davies M, Hayler D, Fabre MA, Mahbubani K, Abascal F, Cagan A, Vassiliou GS, Baxter J, Martincorena I, Stratton MR, Kent DG, Chatterjee K, Parsy KS, Green AR, Nangalia J, Laurenti E, Campbell PJ. Clonal dynamics of haematopoiesis across the human lifespan. Nature. 2022;606(7913):343\u201350.","journal-title":"Nature"},{"issue":"Mar\u2013Apr","key":"8835_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diff.2018.01.001","volume":"100","author":"E Fiorini","year":"2018","unstructured":"Fiorini E, Santoni A, Colla S. Dysfunctional telomeres and hematological disorders. Differentiation. 2018;100(Mar\u2013Apr):1\u201311.","journal-title":"Differentiation"},{"issue":"8","key":"8835_CR37","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1158\/2159-8290.CD-18-1474","volume":"9","author":"ER Adelman","year":"2019","unstructured":"Adelman ER, Huang HT, Roisman A, Olsson A, Colaprico A, Qin T, Lindsley RC, Bejar R, Salomonis N, Grimes HL, Figueroa ME. Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia. Cancer Discov. 2019;9(8):1080\u2013101.","journal-title":"Cancer Discov"},{"issue":"1","key":"8835_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3324\/haematol.2018.211342","volume":"105","author":"E Mejia-Ramirez","year":"2020","unstructured":"Mejia-Ramirez E, Florian MC. Understanding intrinsic hematopoietic stem cell aging. Haematologica. 2020;105(1):22\u201337.","journal-title":"Haematologica"},{"issue":"6","key":"8835_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.stem.2008.11.003","volume":"3","author":"G Sauvageau","year":"2008","unstructured":"Sauvageau G, Perreault C. Killer granzyme B linked to N-myc- and c-myc-dependent HSC survival: isn\u2019t that comyc? Cell Stem Cell. 2008;3(6):579\u201380.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"8835_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.stem.2008.09.005","volume":"3","author":"E Laurenti","year":"2008","unstructured":"Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN, Bernstein ID, Trumpp A. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell. 2008;3(6):611\u201324.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"8835_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13287-024-04008-4","volume":"15","author":"Y Xinyi","year":"2024","unstructured":"Xinyi Y, Vladimirovich RI, Beeraka NM, Satyavathi A, Kamble D, Nikolenko VN, Lakshmi AN, Basappa B, Reddy YP, Fan R, Liu J. Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies. Stem Cell Res Ther. 2024;15(1):401.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"8835_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41232-020-00138-3","volume":"40","author":"S Kurosawa","year":"2020","unstructured":"Kurosawa S, Iwama A. Aging and leukemic evolution of hematopoietic stem cells under various stress conditions. Inflamm Regen. 2020;40(1):29.","journal-title":"Inflamm Regen"},{"issue":"1","key":"8835_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","volume":"23","author":"M Jeong","year":"2018","unstructured":"Jeong M, Park HJ, Celik H, Ostrander EL, Reyes JM, Guzman A, Rodriguez B, Lei Y, Lee Y, Ding L, Guryanova OA, Li W, Goodell MA, Challen GA. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Rep. 2018;23(1):1\u201310.","journal-title":"Cell Rep"},{"issue":"1","key":"8835_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13045-022-01336-x","volume":"15","author":"EA Medina","year":"2022","unstructured":"Medina EA, Delma CR, Yang FC. ASXL1\/2 mutations and myeloid malignancies. J Hematol Oncol. 2022;15(1):127.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"8835_CR45","first-page":"2551","volume":"108","author":"O Marin-Bejar","year":"2023","unstructured":"Marin-Bejar O, Romero-Moya D, Rodriguez-Ubreva J, Distefano M, Lessi F, Aretini P, Liquori A, Casta\u00f1o J, Kozyra E, Kotmayer L, Bueno C, Cervera J, Rodriguez-Gallego JC, Nomdedeu JF, Murillo-Sanju\u00e1n L, De Heredia CD, P\u00e9rez-Martinez A, L\u00f3pez-Cadenas F, Mart\u00ednez-Laperche C, Dorado-Herrero N, Marco FM, Pr\u00f3sper F, Menendez P, Valc\u00e1rcel D, Ballestar E, B\u00f6d\u00f6r C, Bigas A, Catal\u00e1 A, Wlodarski MW, Giorgetti A. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. Haematologica. 2023;108(9):2551\u20137.","journal-title":"Haematologica"},{"issue":"2","key":"8835_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/blood-2014-04-567024","volume":"125","author":"E Chen","year":"2015","unstructured":"Chen E, Schneider RK, Breyfogle LJ, Rosen EA, Poveromo L, Elf S, Ko A, Brumme K, Levine R, Ebert BL, Mullally A. Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood. 2015;125(2):327\u201335.","journal-title":"Blood"},{"issue":"16","key":"8835_CR47","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.2022017578","volume":"141","author":"D Luque Paz","year":"2023","unstructured":"Luque Paz D, Kralovics R, Skoda RC. Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood. 2023;141(16):1909\u201321.","journal-title":"Blood"},{"key":"8835_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms1826","volume":"3","author":"MT Bocker","year":"2012","unstructured":"Bocker MT, et al. Hydroxylation of 5-methylcytosine by Tet2 maintains the active state of the mammalian hoxa cluster. Nat Commun. 2012;3:1\u201312.","journal-title":"Nat Commun"},{"issue":"10","key":"8835_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41408-022-00739-w","volume":"12","author":"F Huang","year":"2022","unstructured":"Huang F, Sun J, Chen W, Zhang L, He X, Dong H, Wu Y, Wang H, Li Z, Ball B, Khaled S, Marcucci G, Li L. Tet2 deficiency promotes MDS-associated leukemogenesis. Blood Cancer J. 2022;12(10):141.","journal-title":"Blood Cancer J"},{"key":"8835_CR50","doi-asserted-by":"crossref","unstructured":"Talarmin L, Clarke MA, Shorthouse D, Cabrera-Cosme L, Kent DG, Fisher J, Hall BA. HOXA9 has the hallmarks of a biological switch with implications in blood cancers. Nat Commun. 2022;13(1):6087.","DOI":"10.1038\/s41467-022-33189-w"},{"issue":"1","key":"8835_CR51","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1038\/s41467-022-33189-w","volume":"13","author":"L Talarmain","year":"2022","unstructured":"Talarmain L, Clarke MA, Shorthouse D, Cabrera-Cosme L, Kent DG, Fisher J, Hall BA. HOXA9 has the hallmarks of a biological switch with implications in blood cancers. Nat Commun. 2022;13(1):5829.","journal-title":"Nat Commun"},{"issue":"7","key":"8835_CR52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortmann","year":"2015","unstructured":"Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, Baxter EJ, Massie CE, Papaemmanuil E, Menon S, Godfrey AL, Dimitropoulou D, Guglielmelli P, Bellosillo B, Besses C, D\u00f6hner K, Harrison CN, Vassiliou GS, Vannucchi A, Campbell PJ, Green AR. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015;372(7):601\u201312.","journal-title":"N Engl J Med"},{"issue":"11","key":"8835_CR53","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1038\/bcj.2015.95","volume":"5","author":"S Cerquozzi","year":"2015","unstructured":"Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015;5(11):e366.","journal-title":"Blood Cancer J"},{"issue":"14","key":"8835_CR54","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014;123(14):2220\u20138.","journal-title":"Blood"},{"issue":"3","key":"8835_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1084\/jem.20151438","volume":"213","author":"X Yue","year":"2016","unstructured":"Yue X, Trifari S, \u00c4ij\u00f6 T, Tsagaratou A, Pastor WA, Zepeda-Mart\u00ednez JA, Lio CW, Li X, Huang Y, Vijayanand P, L\u00e4hdesm\u00e4ki H, Rao A. Control of Foxp3 stability through modulation of TET activity. J Exp Med. 2016;213(3):377\u201397.","journal-title":"J Exp Med"},{"issue":"4","key":"8835_CR56","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.bbrc.2018.07.021","volume":"503","author":"E Wakamatsu","year":"2018","unstructured":"Wakamatsu E, Omori H, Kawano A, Ogawa S, Abe R. Strong TCR stimulation promotes the stabilization of Foxp3 expression in regulatory T cells induced in vitro through increasing the demethylation of Foxp3 CNS2. Biochem Biophys Res Commun. 2018;503(4):2597\u2013602.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"8835_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/dxx049","volume":"29","author":"K Someya","year":"2017","unstructured":"Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Takamura-Enya T, Yoshimura A. Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. Int Immunol. 2017;29(8):365\u201375.","journal-title":"Int Immunol"},{"issue":"2","key":"8835_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","volume":"43","author":"R Yang","year":"2015","unstructured":"Yang R, Qu C, Zhou Y, Konkel JE, Shi S, Liu Y, Chen C, Liu S, Liu D, Chen Y, Zandi E, Chen W, Zhou Y, Shi S. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. Immunity. 2015;43(2):251\u201363.","journal-title":"Immunity"},{"key":"8835_CR59","doi-asserted-by":"crossref","unstructured":"Herbrich S, Chaib M, Anandhan S. Tet2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy. solid tumors Cancer Cell. 2025;44:187\u2013e2027.","DOI":"10.1016\/j.ccell.2025.09.011"},{"key":"8835_CR60","doi-asserted-by":"crossref","unstructured":"Pan W, Zhu S, Qu K, Meeth K, Cheng J, He K, Ma H, Liao Y, Wen X, Roden C, Tobiasova Z, Wei Z, Zhao J, Liu J, Zheng J, Guo B, Khan SA, Bosenberg M, Flavell RA, Lu J. The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression. Immunity. 2017;47(2):284\u2013e2975.","DOI":"10.1016\/j.immuni.2017.07.020"},{"key":"8835_CR61","doi-asserted-by":"crossref","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, Jiang L, Zhang B, Yang Y, Wang X, Ren X, Bei JX, Hu X, Bu Z, Ji J, Zhang Z. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792\u2013e80923.","DOI":"10.1016\/j.cell.2021.01.010"},{"issue":"4","key":"8835_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2326-6066.CIR-21-0588","volume":"10","author":"AM Mujal","year":"2022","unstructured":"Mujal AM, Combes AJ, Rao AA, Binnewies M, Samad B, Tsui J, Boissonnas A, Pollack JL, Arg\u00fcello RJ, Meng MV, Porten SP, Ruhland MK, Barry KC, Chan V, Krummel MF. Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer. Cancer Immunol Res. 2022;10(4):403\u201319.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"8835_CR63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.stem.2023.05.001","volume":"30","author":"KH Hu","year":"2023","unstructured":"Hu KH, Kuhn NF, Courau T, Tsui J, Samad B, Ha P, Kratz JR, Combes AJ, Krummel MF. Transcriptional space-time mapping identifies concerted immune and stromal cell patterns and gene programs in wound healing and cancer. Cell Stem Cell. 2023;30(6):885\u2013e90310.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"8835_CR64","doi-asserted-by":"publisher","first-page":"e20240957","DOI":"10.1084\/jem.20240957","volume":"222","author":"A Ray","year":"2025","unstructured":"Ray A, Hu KH, Kersten K, Courau T, Kuhn NF, Zaleta-Linares I, Samad B, Combes AJ, Krummel MF. Targeting CD206\u2009+\u2009macrophages disrupts the establishment of a key antitumor immune axis. J Exp Med. 2025;222(1):e20240957.","journal-title":"J Exp Med"},{"issue":"10","key":"8835_CR65","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","volume":"145","author":"G Feng","year":"2022","unstructured":"Feng G, Bajpai G, Ma P, Koenig A, Bredemeyer A, Lokshina I, Lai L, F\u00f6rster I, Leuschner F, Kreisel D, Lavine KJ. CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells. Circulation. 2022;145(10):765\u201382.","journal-title":"Circulation"},{"key":"8835_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659\u2013702.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"8835_CR67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12035-025-05550-9","volume":"63","author":"A Hasheminia","year":"2025","unstructured":"Hasheminia A, Mann S, Liblik K, El-Diasty M. The CCL17\/CCL22-CCR4 Axis in Pain Pathogenesis: A Comprehensive Review of Immune-Mediated Mechanisms and Therapeutic Opportunities. Mol Neurobiol. 2025;63(1):174.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"8835_CR68","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3324\/haematol.2019.233924","volume":"106","author":"S Fa\u00f1anas-Baquero","year":"2021","unstructured":"Fa\u00f1anas-Baquero S, Orman I, Becerra Aparicio F, Bermudez de Miguel S, Garcia Merino J, Ya\u00f1ez R, Fernandez Sainz Y, S\u00e1nchez R, Dessy-Rodr\u00edguez M, Alberquilla O, Alfaro D, Zapata A, Bueren JA, Segovia JC, Quintana-Bustamante O. Natural estrogens enhance the engraftment of human hematopoietic stem and progenitor cells in immunodeficient mice. Haematologica. 2021;106(6):1659\u201370.","journal-title":"Haematologica"},{"issue":"1","key":"8835_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15283\/ijsc.2015.8.1.18","volume":"8","author":"HR Heo","year":"2015","unstructured":"Heo HR, Chen L, An B, Kim KS, Ji J, Hong SH. Hormonal regulation of hematopoietic stem cells and their niche: a focus on estrogen. Int J Stem Cells. 2015;8(1):18\u201323.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"8835_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-016-0111-9","volume":"6","author":"HR Kim","year":"2016","unstructured":"Kim HR, Lee JH, Heo HR, Yang SR, Ha KS, Park WS, Han ET, Song H, Hong SH. Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway. Cell Biosci. 2016;6(1):50.","journal-title":"Cell Biosci"},{"key":"8835_CR71","doi-asserted-by":"crossref","unstructured":"Broome R, Chernukhin I, Jamieson S, Kishore K, Papachristou EK, Mao SQ, Tejedo CG, Mahtey A, Theodorou V, Groen AJ, D\u2019Santos C, Balasubramanian S, Farcas AM, Siersb\u00e6k R, Carroll JS. Tet2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell Rep. 2021;34(8):108776.","DOI":"10.1016\/j.celrep.2021.108776"},{"key":"8835_CR72","doi-asserted-by":"crossref","unstructured":"Wang L, Ozark PA, Smith ER, Zhao Z, Marshall SA, Rendleman EJ, Piunti A, Ryan C, Whelan AL, Helmin KA, Morgan MA, Zou L, Singer BD, Shilatifard A. Tet2 coactivates gene expression through demethylation of enhancers. Sci Adv. 2018;4(11):eaau6986.","DOI":"10.1126\/sciadv.aau6986"},{"issue":"3","key":"8835_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/intimm\/dxl151","volume":"19","author":"MJ Polanczyk","year":"2007","unstructured":"Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol. 2007;19(3):337\u201343.","journal-title":"Int Immunol"},{"key":"8835_CR74","doi-asserted-by":"crossref","unstructured":"Luo CY, Wang L, Sun C, Li DJ. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol. 2011;8(1):50\u20138.","DOI":"10.1038\/cmi.2010.54"},{"key":"8835_CR75","doi-asserted-by":"crossref","unstructured":"Li X, Wang L, Qin X, Chen X, Li L, Huang Z, Zhang W, Liu W. Estrogens revert neutrophil hyperplasia by inhibiting Hif1\u03b1-cMyb pathway in zebrafish myelodysplastic syndromes models. Cell Death Discov. 2022;8(1):323.","DOI":"10.1038\/s41420-022-01121-2"},{"key":"8835_CR76","doi-asserted-by":"crossref","unstructured":"Gravina GL, Marampon F, Piccolella M, Motta M, Ventura L, Pomante R, Popov VM, Zani BM, Pestell RG, Tombolini V, Jannini EA, Festuccia C. Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. Endocrinology. 2011;152(12):4550\u201361.","DOI":"10.1210\/en.2011-1056"},{"key":"8835_CR77","doi-asserted-by":"crossref","unstructured":"Dawoud AAZ, Tapper WJ, Cross NCP. Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by Tet2, TP53, and CBL mutations. Sci Adv. 2023;9(16):eade9746.","DOI":"10.1126\/sciadv.ade9746"},{"issue":"1","key":"8835_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13148-022-01404-6","volume":"15","author":"A Taira","year":"2023","unstructured":"Taira A, Palin K, Kuosmanen A, V\u00e4lim\u00e4ki N, Kuittinen O, Kuismin O, Kaasinen E, Rajam\u00e4ki K, Aaltonen LA. Vitamin C boosts DNA demethylation in Tet2 germline mutation carriers. Clin Epigenetics. 2023;15(1):7.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"8835_CR79","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1093\/nar\/gnh090","volume":"32","author":"R Kemp","year":"2004","unstructured":"Kemp R, Ireland H, Clayton E, Houghton C, Howard L, Winton DJ. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res. 2004;32(11):e92.","journal-title":"Nucleic Acids Res"},{"key":"8835_CR80","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/leu.2013.77","volume":"27","author":"A Mupo","year":"2013","unstructured":"Mupo A, Celani L, Dovey O, Cooper JL, Grove C, Rad R, Sportoletti P, Falini B, Bradley A, Vassiliou G. S. A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. Leukemia. 2013;27:1917\u201320.","journal-title":"Leukemia"},{"issue":"11","key":"8835_CR81","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1182\/bloodadvances.2022008591","volume":"7","author":"C Wang","year":"2023","unstructured":"Wang C, Tu Z, Cai X, Wang W, Davis AK, Nattamai K, Paranjpe A, Dexheimer P, Wu J, Huang FL, Geiger H, Huang G, Zheng Y. A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation. Blood Adv. 2023;7(11):2590\u2013605.","journal-title":"Blood Adv"},{"issue":"1","key":"8835_CR82","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1038\/s41467-025-61552-0","volume":"16","author":"L Li","year":"2025","unstructured":"Li L, Lei Y, Li Y, Xie Y, Hui P, Zang X, Wu W, Wu F, Fan J, Wang J, Chen J, Chen Z, Hou Y. EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism and alleviating endoplasmic reticulum stress. Nat Commun. 2025;16(1):6247.","journal-title":"Nat Commun"},{"issue":"23","key":"8835_CR83","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1182\/bloodadvances.2022007804","volume":"6","author":"YJ Huang","year":"2022","unstructured":"Huang YJ, Chen JY, Yan M, Davis AG, Miyauchi S, Chen L, Hao Y, Katz S, Bejar R, Abdel-Wahab O, Fu XD, Zhang DE. RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS. Blood Adv. 2022;6(23):6078\u201392.","journal-title":"Blood Adv"},{"issue":"1","key":"8835_CR84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stemcr.2016.06.002","volume":"7","author":"T Velasco-Hernandez","year":"2016","unstructured":"Velasco-Hernandez T, S\u00e4w\u00e9n P, Bryder D, Cammenga J. Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis. Stem Cell Rep. 2016;7(1):11\u20138.","journal-title":"Stem Cell Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08835-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:33:27Z","timestamp":1788935607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8835"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08835-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to the guidance on ethical treatment of experimental animals: Ministry of Science and Technology(2006)no. 398, the national experimental animal management issued by the State Scientific and Technological Commission of the People\u2019s Republic of China in 2013,and the GB\/T 35892\u2009\u2212\u20092018 Laboratory animal-Guideline for ethical review of animal welfare, the animal experiments were approved by the Animal Ethics Committee of Xiyuan Hospital of China Academy of Chinese Medical Sciences(2022XLC065).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1160"}}